0 projects

PES2020-Prosj.etabl.støtte H2020

Preclinical and toxicology and clinical phase 1 program for vitamin K2 pro-drug (pro-MK-7)

Kappa Bioscience AS is an innovative Norwegian chemical and life science company whose primary business focus has been to produce vitamin K2 of high purity and with high biological activity to the consumer market (dietary supplements). Due to our understanding of vitamin K2 and its role in the re...

Awarded: NOK 0.12 mill.

Project Period: 2016-2017

Location: Oslo

PES2020-Prosj.etabl.støtte H2020

A clinical proof-of-concept program for vitamin K2 prodrug in the treatment of calciphylaxis cutis

Due to the role of vitamin K2 role in the regulation of bone and soft tissue calcification, a drug development program for the use of vitamin K2 in the treatment of calciphylaxis cutis has now been planned. A patented pro-drug of vitamin K2 is being synthesised, formulated and will be taken throu...

Awarded: NOK 0.12 mill.

Project Period: 2016-2017

Location: Oslo

BIA-Brukerstyrt innovasjonsarena

Vitamin K2 derivative - new drug for treatment of cardiovascular diesease (CVD)

Prosjektets mål er å identifisere og å dokumentere en «pro-drug» med forbedrete egenskaper i forhold til MK-7; et produkt som kan utvikles som et legemiddel for behandling av hjerte-kar sykdom. Prosjekt har vært vellykket og vi har identifisert en kandidat (pro-drug) som har forbedrete egenskap...

Awarded: NOK 2.3 mill.

Project Period: 2011-2014

Location: Oslo